MITSUCHEMPLAST Q4 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹86.79 Cr
verification pending
Revenue YoY
3.9%
reported change
EBITDA
₹14.23 Cr
latest reported figure
Source
bse pending
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Mitsu Chem Plast delivered a standout Q4 FY26 with EBITDA margin at 16.45%, up 736bps YoY—though management flagged 1-2pp as one-off benefit from geopolitical-driven HDPE price surge. Net profit doubled (+117.9%) to ₹7.72 crore. Full-year FY26 saw total income of ₹350.85 crore (5.4% YoY) with EBITDA at ₹34.66 crore (+48.9%) and PAT at ₹15.62 crore (+115.4%). The company guided 30% revenue growth for FY27 (~₹455 crore), expecting volume to scale from 21,000 tons to 27,000 tons. The ₹1,000 crore FY28 target remains intact, requiring near-tripling of revenue. A new fully-automatic IBC plant at Kalapur (targeting Q2 FY27) and 175+ new customer additions (focused on profitability over top-line) underpin growth plans. Key risk: HDPE prices remain 30% above pre-war levels; any reversal could compress Q4's elevated margins, as management noted Q4's 16.45% is not fully sustainable (targeting 10%+ sustainable). The 40-45% capacity utilization breakeven for new capex also introduces near-term margin dilution risk if exports scale slower than expected.
Colored figures show movement against the previous available record.
Guidance to track
- Management guided minimum 30% revenue growth for FY27, implying ~₹455 crore revenue, driven by volume expansion to 27,000 tons from current 21,000 tons and new IBC plant commissioning.
- The new fully-automatic IBC (Intermediate Bulk Container) plant at Kalapur facility is on track to start operations in Q2 FY27, expected to be a meaningful growth and margin driver given limited competition.
- Long-term target of ₹1,000 crore annual revenue by FY28, with healthcare/furniture segment expected to grow to ~20% mix from current 16%, requiring near-tripling of current revenue.
- Management stated 10%+ EBITDA margin is sustainable for the business; Q4's 16.45% included 1-2pp one-off benefit. Internal targets are slightly above 10%.
Risks flagged
- HDPE prices remain 30% above pre-war levels. Any reversal could reverse Q4's margin gains, as raw material prices are passed through with a small time lag. Management noted the 16.45% margin is not fully sustainable.
- Analyst questioned whether high-margin export demand will scale as expected; management stated blow molding industry typically has less than one month order visibility, making the 30% growth guidance more of an internal target than confirmed order-backed forecast.
- Minimum 40-45% capacity utilization required for new capex not to dilute margins. With multiple expansion projects ongoing, any slowdown in demand recovery could pressure near-term profitability.
- Analyst asked why Mitsu Chem Plast's margins are significantly lower than peer Time Technoplast (15%+ EBITDA margin stably) despite similar products. Management declined to comment, redirecting to quarter-on-quarter improvement narrative without addressing structural gap.
Key quotes
- I think 10% [EBITDA margin] is sustainable very, very sustainable so minimum 10% will sustain... we will make sure that minimum 10% plus margin should be there.
- What I said last war situation had become 40% [HDPE price increase]. And now it is 30%. It cannot remain 30%. So it will definitely come within one or two months, it will normalize.
- We are targeting around 30% growth [for FY27]. This revenue growth is not significant increase because of rate increase... we are talking on the same volume only.
Research modules